Needham & Company Maintains a 'Buy' on Xyratex (XRTX); F1Q11 Toward Low-end; Reducing Outlook on SI Weakness, but Largely Anticipated
Tweet Send to a Friend
Needham & Company maintains a 'Buy' on Xyratex (NASDAQ: XRTX), PT lowered by $1 to $15.
Needham analyst says, "Although ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "Although ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
